TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: ART uptake and adherence through 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of antihypertensive agents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Need for more support
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Event-related Brain Oscillation: Right Posterior Theta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Spatial Recall performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Retention at end of active phase
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Retention at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Retention at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Depth of insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WBC in cell product
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Lymphocytes and Monocytes in cell product
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: ECP Procedure runtime
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patellofemoral Joint Alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pitching performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: batting performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity, specificity, positive/negative predictive value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standardized incidence ratio of first invasive cancer
Endpoint domain: Mortality/survival
Primary endpoint: Residual myometrial thickness at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of infants with PDA closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oral Mucositis severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Atrial Arrythmias (AA) burden and vascular stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cognitive function test (MoCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: EQ-5D-5L Quality of Life questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Ischaemic events (systemic, myocardial and cerebral)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Inflammatory activation of leukocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Initial Quality of Recover-15 (QoR-15) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in cross sectional area of m. quadriceps femoris
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: malignancy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 30-Day Hospital Readmissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Peak Serum Concentration of adalimumab (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Concentration-time Curve of adalimumab (ABC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Concentration-Time Curve of adalimumab (ABC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interval to ovulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Area under the concentration-time curve (AUC) from time 0 extrapolated to infinite time (AUC0-inf) of CSL312
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor evoked potentials recruitment curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Intracortical excitability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Intramuscular coherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Force control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Time to placement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of new disease progression during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Overbite distance correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Return of Spontaneous Circulation (ROSC) at hospital arrival
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite events of stroke or systemic embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bacteria culture and Polymerase chain reaction exam
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduction of glycated hemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of number bowel movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change of stool type
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Finnegan Neonatal Abstinence Scoring System
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of auditory evoked potentials as measured by EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: morphine needed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Slope of change in rumination scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum Observed Concentration (Cmax) of [14C]-BIIB091-Derived Materials in Plasma and Whole Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Reach Maximum Observed Concentration (Tmax) of [14C]-BIIB091-Derived Materials in Plasma and Whole Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve From Time 0 to Infinity (AUCinf) of [14C]-BIIB091-Derived Materials in Plasma and Whole Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Macrophage Migration Inhibitory Factor Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence of Normal Serum Potassium Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of patients who requested analgesia
Endpoint domain: Adverse events/effects
Primary endpoint: Fugl-Meyer Assessment, Upper Extremity sub-scale (FMA-UE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of target lesion failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of mental health events
Endpoint domain: Adverse events/effects
Primary endpoint: Time to decision to recommend CT
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area Under the Concentration Versus Time Curve (AUC) of HRS9531 From Time Zero to Tlast (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration of HRS9531 (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve (AUC) of HRS9531 From Time Zero to Infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment response to mepolizumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD)/Maximum Administered Dose (MAD)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum isometric force of plantar flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Mediterranean Diet Compliance Scale (MEDAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chronic disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oxygen consumption during the recovery period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention adherence (time spent)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevalence of heart failure phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quick Disability of Arm and Shoulder (DASH)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of asthma-related hospitalizations and emergency department visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Presence of pulmonary hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Stain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients receiving best practice sedo-analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Visual Analog Scale of Pain (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cutaneous sensitization to fenugreek
Endpoint domain: Adverse events/effects
Primary endpoint: Numerical Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Veterans RAND 36-item Health Survey (VR-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Plasma Concentration of JNJ-61393215
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PTS symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: General quality of life score (Eq5D-3L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Psychological distress (PHQ8)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning
Primary endpoint: Ventricular sphericity indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Caregiver Depression, Anxiety and Stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Caregiver Strain
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in Caregiver Self-Reported Emotional Health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Depressive Symptom Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of Major Depression
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of study as measured by the Treatment Acceptance Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of study as documented in in-depth interviews
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of study as measured by session attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: postoperative atelectasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time hemoglobin levels are maintained within acceptable range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of subjects who achieve transfusion independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from kyphosis angle at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from lordosis angle at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from the global tilt at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from Global Alignment and Proportion (GAP) score at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Severity and incidence of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Patient Radiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Patient cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Daily Symptom Reflux Diary (DRSD)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Reflux Symptom Index (RSI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of unscheduled consultations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients with excellent functional outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: sO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Biomarkers of response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preoperative fitness based on oxygen uptake (VO2) at the ventilatory anaerobic threshold (VAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: M-protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in intestinal microflora
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of participants with PRNT sero-conversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of children who develop adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Shrinkage of cyst
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in depression severity scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of patients achieving clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in perception of pain, referred to wrist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in hand and wrist function related with difficulties in performing daily living activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of patients with very good partial response (VGPR) or better
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comprehensive Coordination Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Area Under The Plasma Concentration Versus Time Curve From Time 0 To The Last Quantifiable Concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under The Plasma Concentration Versus Time Curve From Zero To Infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Airway mucosal damage change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients completing screening mammogram
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in Cornell Scale for Depression in Dementia (CSDD) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Assessment of disease activity by DAS28 (Disease Activity Score for 28 Joints)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Clinical Disease Activity Index (CDAI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Structural joint damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Prevalence of post-traumatic stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to Maximum Observed Concentration (Tmax) of Selpercatinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of head impacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who complete the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants who complete the data collection forms
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: osseointegration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change In Clinical Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Pain After Analgesia Administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of Helicobacter Pylori Infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of appropriate transfusion orders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Test score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Retention test score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Qualitative features of atherosclerotic plaques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebral vasodilator function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of senescent cell types in fibroid and myometrium tissue samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematopoietic colony formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Perioperative hemodynamic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perioperative respiratory complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of prostate cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Recurrence of stone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Engagement on the Patient Activation Measure (PAM13)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Engagement as measured by the Service Engagement Scale (SES)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: symptomatic intracerebral hemorrhage (ICH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Number of patients with neurologic or ophthalmological adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in GDMT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Number of Alcohol Drinks Consumed in a Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of delivering a lifestyle program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion of 75-gram oral glucose tolerance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in St. George's Respiratory Questionnaire (SGRQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to conversion to sinus rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Survey measure of recovery experiences
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Survey measure of need for recovery after work
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Survey measure of insomnia symptoms
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Diary measure of recovery experiences during work and off-work time
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Sleep (objective measure)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in clinical assessment percentiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with Renal dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of patients with Myelosuppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of patients with Myelodysplastic syndrome/acute myeloid leukaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of patients with Hormone release induced crises
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 1,5-anhydroglucitol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Joint Range of Motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Postoperative 24-hour analgesic consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes